Do you want to read an article? Please log in or register.
Comparison of treatment routine using aflibercept: Strict vs. relaxed retreatment regimen (TOLERANT study)-A non-inferiority, randomized controlled trial
Macular Diseases
Related content
Macular Diseases
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
Ophthalmol Ther
Debourdeau E, Beylerian H, Nguyen V, Barthelmes D, Gillies M, Gabrielle PH, Vujosevic S, Otoole L, Puzo M, Creuzot-Garcher C, Wolff B, Daien V, Fight Retinal Blindness! Study Group
doi: 10.1007/s40123-024-00983-2
Lenses
Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine
Br J Ophthalmol
Guemes-Villahoz N, Talavero González P, Porras-Ángel P, Bella-Gala R, Ruiz-Pomeda A, Martin-Garcia B, Hernandez-Garcia E, Gomez de Liaño N, Shah R, Garcia-Feijoo J, Gomez-de-Liaño R
doi: 10.1136/bjo-2024-326852
Macular Diseases
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial
JAMA Ophthalmol
Khanani AM, Campochiaro PA, Graff JM, Marcus DM, Miller D, Mittra RA, Regillo C, Sheth VS, Bobbala A, Gune S, Lin S, Quezada-Ruiz C, Malhotra V
doi: 10.1001/jamaophthalmol.2025.0006
RECOMMENDED
Further Publications
Efficacy and Safety of Different Atropine Regimens for the Treatment of Myopia in Children: Three-Year Results of the MOSAIC Randomized Clinical Trial
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
JAMA Ophthalmol
Loughman J, Lingham G, Nkansah EK, Kobia-Acquah E, Flitcroft DI
doi: 10.1001/jamaophthalmol.2024.5703
Further Publications
Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study: A Randomized Clinical Trial
JAMA Ophthalmol
Warner DB, Jeng BH, Kim J, Liu M, Troxel AB, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Meyer JJ, Lu Y, Twi-Yeboah A, Lee TF, Lopez-Jimenez C, Laury SC, Cohen EJ, ZEDS Trial Research Group
doi: 10.1001/jamaophthalmol.2024.6113
Dry Eye Disease
Efficacy and safety of a lipid-containing artificial tear compared with a non-lipid containing tear: a randomized clinical trial
BMC Ophthalmol
Donnenfeld E, Coats J, Barbour K, Ryan R, Joshi NR, Periman LM
doi: 10.1186/s12886-024-03688-z
Macular DiseasesRetinal Diseases
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial
JAMA Ophthalmol
Pieramici DJ, Awh CC, Chang M, Emanuelli A, Holekamp NM, Hu AY, Suñer IJ, Wykoff CC, Brittain C, Howard D, Quezada-Ruiz C, Santhanakrishnan A, Latkany P
doi: 10.1001/jamaophthalmol.2025.0001
Macular Diseases
Anatomic Outcomes With Faricimab vs. Aflibercept in the Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular AMD
Ophthalmology
Gemmy Cheung CM, Lim JI, Priglinger S, Querques G, Margaron P, Patel S, Souverain A, Willis JR, Yang M, Guymer R
doi: 10.1016/j.ophtha.2024.11.023
Glaucoma and Ocular PressureCataracts
Two-Year Outcomes of Phacogoniotomy vs Phacotrabeculectomy for Advanced Primary Angle-Closure Glaucoma With Cataract: A Noninferiority Randomized Clinical Trial
JAMA Ophthalmol
Song Y, Fan S, Tang L, Lin F, Li F, Lv A, Li X, Wen T, Lu L, Xiao M, Xie L, Zhu X, Tang G, Zhang H, Yan X, Yuan H, Song W, Yang Y, Xu J, Zhou F, Wang Z, Jin L, Liang X, Zhou M, Zhao X, Chen W, Park KH, Barton K, Aung T, Tham CC, Lam DSC, Weinreb RN, Wang N, Zhang X, PVP Study Group
doi: 10.1001/jamaophthalmol.2025.0685